Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: Relevance to alzheimer's disease

Molecular Pharmacology

Volumn 79, Issue 6, 2011, Pages 964-973

  Martín Moreno, Ana María ^a,b   Reigada, David ^a,b,e   Ramírez, Belén G ^a,b,f   Mechoulam, R ^c   Innamorato, Nadia ^b,d   Cuadrado, Antonio ^b,d   De Ceballos, María L ^a,b  

^a INSTITUTO CAJAL   (Spain)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e Molecular Neuroprotection Group   (Spain)

^f MD ANDERSON CANCER CENTER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; ADENOSINE A2A RECEPTOR; ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; CALCIUM; CANNABIDIOL; CANNABINOID; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 2 RECEPTOR AGONIST; CYTOKINE; LIPOPOLYSACCHARIDE; NITRITE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LEARNING; MICROGLIAL ACTIVATION; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ALZHEIMER DISEASE; ANIMALS; BASE SEQUENCE; CANNABIDIOL; CANNABINOIDS; CELLS, CULTURED; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICROGLIA; NITRIC OXIDE; POLYMERASE CHAIN REACTION; RATS; RNA, MESSENGER;

EID: 79956293339     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.071290     Document Type: Article

References (40)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, et al. (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421. (Pubitemid 30349107)
2. Carrier EJ, Auchampach JA, and Hillard CJ (2006) Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci USA 103:7895-7900.
3. Combs CK, Karlo JC, Kao SC, and Landreth GE (2001) beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21:1179-1188. (Pubitemid 32128763)
4. Costa B, Colleoni M, Conti S, Parolaro D, Franke C, Trovato AE, and Giagnoni G (2004) Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn Schmiedebergs Arch Pharmacol 369:294-299. (Pubitemid 38372934)
5. Cui YH, Le Y, Gong W, Proost P, Van Damme J, Murphy WJ, and Wang JM (2002) Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J Immunol 168:434-442. (Pubitemid 34014146)
6. De Petrocellis L, Marini P, Matias I, Moriello AS, Starowicz K, Cristino L, Nigam S, and Di Marzo V (2007) Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma beta-cells. Exp Cell Res 313:2993-3004. (Pubitemid 47135571)
7. 2+ elevations in hippocampal cells. Neuropharmacology 50: 621-631.
8. Esposito G, De Filippis D, Carnuccio R, Izzo AA, and Iuvone T (2006a) The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. J Mol Med 84:253-258. (Pubitemid 43291014)
9. Esposito G, De Filippis D, Maiuri MC, De Stefano D, Carnuccio R, and Iuvone T (2006b) Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. Neurosci Lett 399:91-95.
10. Esposito G, Scuderi C, Savani C, Steardo L Jr, De Filippis D, Cottone P, Iuvone T, Cuomo V, and Steardo L (2007) Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression. Br J Pharmacol 151:1272-1279. (Pubitemid 47255904)
11. Facchinetti F, Del Giudice E, Furegato S, Passarotto M, and Leon A (2003) Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lipopolysaccharide. Glia 41:161-168. (Pubitemid 36262193)
12. Färber K and Kettenmann H (2006) Functional role of calcium signals for microglial function. Glia 54:656-665. (Pubitemid 44629629)
13. Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, Pertwee RG, Ross RA, Mechoulam R, and Fride E (1999) HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc Natl Acad Sci USA 96:14228-14233. (Pubitemid 30000633)
14. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, and Pertwee RG., Herkenha, M, Mackie K, Martin BR, Mechoulan R, Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202.
15. Huffman JW, Liddle J, Yu S, Aung MM, Abood ME, Wiley JL, and Martin BR (1999) 3-(1′,1′-Dimethylbutyl)-1-deoxy-delta-8-THC and related compounds: synthesis and selective ligands for the CB2 receptor. Bioorg Med Chem 7:2905-2914.
16. Iuvone T, Esposito G, Esposito R, Santamaria R, Di Rosa M, and Izzo AA (2004) Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. J Neurochem 89:134-141. (Pubitemid 38420682)
17. Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, and Gordon MN (2002) Microglial activation and β-amyloid deposit reduction caused by nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J Neurosci 22:2246-2254. (Pubitemid 35386524)
18. Kettenmann H, Banati R, and Walz W (1993) Electrophysiological behavior of microglia. Glia 7:93-101.
19. Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, and Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 357:1-9. (Pubitemid 28085115)
20. Light AR, Wu Y, Hughen RW, and Guthrie PB (2006) Purinergic receptors activating rapid intracellular Ca increases in microglia. Neuron Glia Biol 2:125-138.
21. Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, and Feldmann M (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA 97:9561-9566. (Pubitemid 30650815)
22. Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, and Games D (1996) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J Neurosci 16:5795-5811. (Pubitemid 26293401)
23. Mato S, Alberdi E, Ledent C, Watanabe M, and Matute C (2009) CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes. Glia 57:295-306.
24. Mechoulam R, Peters M, Murillo-Rodriguez E, and Hanus LO (2007) Cannabidiol-recent advances. Chem Biodivers 4:1678-1692.
25. Mechoulam R and Shohami E (2007) Endocannabinoids and traumatic brain injury. Mol Neurobiol 36:68-74. (Pubitemid 351360359)
26. Möller T, Kann O, Verkhratsky A, and Kettenmann H (2000) Activation of mouse microglial cells affects P2 receptor signaling. Brain Res 853:49-59. (Pubitemid 30015998)
27. 125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor. Mol Pharmacol 48:970-974.
28. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873-884.
29. Puffenbarger RA, Boothe AC, and Cabral GA (2000) Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia 29:58-69. (Pubitemid 30031134)
30. Ramírez BG, Blázquez C, Gómez del Pulgar T, Guzmán M, and de Ceballos ML (2005) Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 25:1904-1913. (Pubitemid 40289395)
31. Righi M, Mori L, De Libero G, Sironi M, Biondi A, Mantovani A, Donini SD, and Ricciardi-Castagnoli P (1989) Monokine production by microglial cell clones. Eur J Immunol 19:1443-1448. (Pubitemid 19221051)
32. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, and Caput D (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244. (Pubitemid 24268029)
33. Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, et al. (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther 284:644-650. (Pubitemid 28086654)
34. Showalter VM, Compton DR, Martin BR, and Abood ME (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 278:989-999. (Pubitemid 27166944)
35. Tiffany HL, Lavigne MC, Cui YH, Wang JM, Leto TL, Gao JL, and Murphy PM (2002) Amyloid-beta induces chemotaxis and oxidant stress by acting at formyl-peptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J Biol Chem 276:23645-23652.
36. van der Stelt M, Mazzola C, Esposito G, Matias I, Petrosino S, De Filippis D, Micale V, Steardo L, Drago F, Iuvone T, et al. (2006) Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell Mol Life Sci 63:1410-1424. (Pubitemid 43939021)
37. van der Stelt M, Veldhuis WB, Maccarrone M, Bär PR, Nicolay K, Veldink GA, Di Marzo V, and Vliegenthart JF (2002) Acute neuronal injury, excitotoxicity, and the endocannabinoid system. Mol Neurobiol 26:317-346. (Pubitemid 35239807)
38. Waksman Y, Olson JM, Carlisle SJ, and Cabral GA (1999) The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J Pharmacol Exp Ther 288: 1357-1366. (Pubitemid 29254178)
39. Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, and Stella N (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23:1398-1405. (Pubitemid 36258918)
40. Walter L and Stella N (2004) Cannabinoids and neuroinflammation. Br J Pharmacol 141:775-785. (Pubitemid 38446178)